U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 500

1.
Kidney Cancer, Version 1.2021: Featured Updates to the NCCN Guidelines
Robert J. Motzer, Eric Jonasch, Shawna Boyle, Maria I. Carlo, Brandon Manley, Neeraj Agarwal, Ajjai Alva, Katy Beckermann, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Arpita Desai, Saby George, John L. Gore, Naomi Haas, Steven L. Hancock, Christos Kyriakopoulos, Elaine T. Lam, Clayton Lau, Bryan Lewis, David C. Madoff, Brittany McCreery, M. Dror Michaelson, Amir Mortazavi, Lakshminarayanan Nandagopal, Phillip M. Pierorazio, Elizabeth R. Plimack, Lee Ponsky, Sundhar Ramalingam, Brian Shuch, Zachary L. Smith, Bradley Somer, Jeffrey Sosman, Mary A. Dwyer, Angela D. Motter
J Natl Compr Canc Netw. Author manuscript; available in PMC 2023 May 17.
Published in final edited form as: J Natl Compr Canc Netw. 2020 Sep; 18(9): 1160–1170. doi: 10.6004/jnccn.2020.0043
PMCID:
PMC10191771
AbstractArticlePDF–76K
2.
The immunoreactivity of GLI1 and VEGFA is a potential prognostic factor in kidney renal clear cell carcinoma
Anna Kotulak-Chrzaszcz, Jacek Kiezun, Mateusz Czajkowski, Marcin Matuszewski, Jakub Klacz, Bartlomiej E. Krazinski, Janusz Godlewski, Zbigniew Kmiec, Piotr M. Wierzbicki
BMC Cancer. 2023; 23: 1110. Published online 2023 Nov 14. doi: 10.1186/s12885-023-11622-7
PMCID:
PMC10647108
AbstractArticlePDF–2.1M
3.
Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma
Franz Sellner, Eva Compérat, Martin Klimpfinger
Int J Mol Sci. 2023 Nov; 24(22): 16292. Published online 2023 Nov 14. doi: 10.3390/ijms242216292
PMCID:
PMC10671160
AbstractArticlePDF–567K
4.
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma
Aurel Prosz, Haohui Duan, Viktoria Tisza, Pranshu Sahgal, Sabine Topka, Gregory T. Klus, Judit Börcsök, Zsofia Sztupinszki, Timothy Hanlon, Miklos Diossy, Laura Vizkeleti, Dag Rune Stormoen, Istvan Csabai, Helle Pappot, Joseph Vijai, Kenneth Offit, Thomas Ried, Nilay Sethi, Kent W. Mouw, Sandor Spisak, Shailja Pathania, Zoltan Szallasi
Sci Rep. 2023; 13: 20567. Published online 2023 Nov 23. doi: 10.1038/s41598-023-47946-4
PMCID:
PMC10667362
AbstractArticlePDF–1.2M
5.
SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer
Hanyu Rao, Changwei Liu, Aiting Wang, Chunxiao Ma, Yue Xu, Tianbao Ye, Wenqiong Su, Peijun Zhou, Wei-Qiang Gao, Li Li, Xianting Ding
Nat Commun. 2023; 14: 7572. Published online 2023 Nov 21. doi: 10.1038/s41467-023-43378-w
PMCID:
PMC10663509
AbstractArticlePDF–3.8M
6.
Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma
Xi Zhang, Mingcong Zhang, Lebin Song, Shuai Wang, Xiyi Wei, Wenchuan Shao, Ninghong Song
Sci Rep. 2023; 13: 20266. Published online 2023 Nov 20. doi: 10.1038/s41598-023-46577-z
PMCID:
PMC10662159
AbstractArticlePDF–6.8M
7.
ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma
Tushuai Li, Longjiang Xu, Zhe Wei, Shaomei Zhang, Xingyu Liu, Yanzi Yang, Yue Gu, Jie Zhang
Mol Cancer. 2023; 22: 184. Published online 2023 Nov 18. doi: 10.1186/s12943-023-01871-2
PMCID:
PMC10656961
AbstractArticlePDF–3.6M
8.
CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma
Lv Tian, Yiming Wang, Zhiyuan Zhang, Xuechao Feng, Fengjun Xiao, Minru Zong
Eur J Med Res. 2023; 28: 531. Published online 2023 Nov 18. doi: 10.1186/s40001-023-01487-8
PMCID:
PMC10656955
AbstractArticlePDF–7.5M
9.
Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role
Shuangze Zhong, Shangjin Chen, Hansheng Lin, Yuancheng Luo, Jingwei He
BMC Urol. 2023; 23: 186. Published online 2023 Nov 15. doi: 10.1186/s12894-023-01357-9
PMCID:
PMC10652602
AbstractArticlePDF–12M
10.
From Fruit Waste to Medical Insight: The Comprehensive Role of Watermelon Rind Extract on Renal Adenocarcinoma Cellular and Transcriptomic Dynamics
Chinreddy Subramanaym Reddy, Purushothaman Natarajan, Padma Nimmakayala, Gerald R. Hankins, Umesh K. Reddy
Int J Mol Sci. 2023 Nov; 24(21): 15615. Published online 2023 Oct 26. doi: 10.3390/ijms242115615
PMCID:
PMC10647773
AbstractArticlePDF–2.2M
11.
Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of Kidney Cancer
Zangbéwendé Guy Ouedraogo, Florian Ceruti, Mathis Lepage, Mathilde Gay-Bellile, Nancy Uhrhammer, Flora Ponelle-Chachuat, Yannick Bidet, Maud Privat, Mathias Cavaillé
Genes (Basel) 2023 Nov; 14(11): 1991. Published online 2023 Oct 25. doi: 10.3390/genes14111991
PMCID:
PMC10671640
AbstractArticlePDF–291K
12.
STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
Zi-Yuan Bai, Lu-Shan Peng, Run-Qi Li, Xianchu Peng, Zhe Yang
Aging (Albany NY) 2023 Oct 31; 15(20): 11286–11297. Published online 2023 Oct 20. doi: 10.18632/aging.205127
PMCID:
PMC10637789
AbstractArticlePDF–1.6M
13.
Branched‐chain keto‐acid dehydrogenase kinase regulates vascular permeability and angiogenesis to facilitate tumor metastasis in renal cell carcinoma
Kunao Yang, Chunlan Xu, Huimin Sun, Zuodong Xuan, Yankuo Liu, Jinxin Li, Yang Bai, Zeyuan Zheng, Yue Zhao, Zhiyuan Shi, Jianzhong Zheng, Chen Shao
Cancer Sci. 2023 Nov; 114(11): 4270–4285. Published online 2023 Sep 16. doi: 10.1111/cas.15956
PMCID:
PMC10637060
AbstractArticlePDF–60M
14.
STAT3 phosphorylation at serine 727 activates specific genetic programs and promotes clear cell renal cell carcinoma (ccRCC) aggressiveness
J. Arévalo, I. Campoy, M. Durán, S. Nemours, A. Areny, M. Vall-Palomar, C. Martínez, G. Cantero-Recasens, A. Meseguer
Sci Rep. 2023; 13: 19552. Published online 2023 Nov 9. doi: 10.1038/s41598-023-46628-5
PMCID:
PMC10636117
AbstractArticlePDF–5.7M
15.
Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma
Shuai Liu, Yu Yao, Mingyu Hou, Jingchang Mei, Lijiang Sun, Guiming Zhang
BMC Cancer. 2023; 23: 1079. Published online 2023 Nov 8. doi: 10.1186/s12885-023-11589-5
PMCID:
PMC10634106
AbstractArticlePDF–14M
16.
A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress
Laxminarayan Rawat, Murugabaskar Balan, Yuzuru Sasamoto, Akash Sabarwal, Soumitro Pal
Redox Biol. 2023 Dec; 68: 102945. Published online 2023 Oct 21. doi: 10.1016/j.redox.2023.102945
PMCID:
PMC10628632
AbstractArticlePDF–12M
17.
Racial Disparities in MiT Family Translocation Renal Cell Carcinoma
Xiaofan Lu, Nassim Tawanaie Pour Sedehi, Xiaoping Su, Fangrong Yan, Omar Alhalabi, Nizar M Tannir, Gabriel G Malouf
Oncologist. 2023 Nov; 28(11): 1009–1013. Published online 2023 Jun 14. doi: 10.1093/oncolo/oyad173
PMCID:
PMC10628562
AbstractArticlePDF–7.5M
18.
CENPE and LDHA were potential prognostic biomarkers of chromophobe renal cell carcinoma
Hui-feng Wu, Hao Liu, Zhe-wei Zhang, Ji-min Chen
Eur J Med Res. 2023; 28: 481. Published online 2023 Nov 4. doi: 10.1186/s40001-023-01449-0
PMCID:
PMC10625266
AbstractArticlePDF–2.5M
19.
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT
Costantino Ricci, Francesca Ambrosi, Tania Franceschini, Francesca Giunchi, Alessia Grillini, Eugenia Franchini, Marco Grillini, Riccardo Schiavina, Francesco Massari, Veronica Mollica, Valentina Tateo, Federico Mineo Bianchi, Lorenzo Bianchi, Matteo Droghetti, Thais Maloberti, Giovanni Tallini, Maurizio Colecchia, Andres Martin Acosta, João Lobo, Kiril Trpkov, Michelangelo Fiorentino, Dario de Biase
Virchows Arch. 2023; 483(5): 687–698. Published online 2023 Oct 17. doi: 10.1007/s00428-023-03673-9
PMCID:
PMC10673759
AbstractArticlePDF–1.9M
20.
Comparative analysis identifies genetic and molecular factors associated with prognostic clusters of PANoptosis in glioma, kidney and melanoma cancer
Raghvendra Mall, Thirumala-Devi Kanneganti
Sci Rep. 2023; 13: 20962. Published online 2023 Nov 28. doi: 10.1038/s41598-023-48098-1
PMCID:
PMC10684528
AbstractArticlePDF–10M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center